Registry for lead extraction from pacemakers and defibrillators
The Oregon Health & Science University Cardiac Implantable Electronic Device Extraction Registry
This study collects information from patients who have had lead extraction from their pacemakers and defibrillators to better understand the reasons for the procedure and its results.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Sex | All |
| Sponsor | Oregon Health and Science University Academic / other |
| Locations | 1 site (Portland, Oregon) |
| Trial ID | NCT03847025 on ClinicalTrials.gov |
What this trial studies
This observational registry collects and analyzes data from patients who have undergone lead extraction procedures for pacemakers and implantable cardioverter defibrillators at Oregon Health and Science University. The study focuses on patient characteristics, procedural specifications, indications for lead extraction, and outcomes. By compiling this data into a comprehensive database, the research aims to enhance understanding of the factors influencing lead extraction and its associated complications.
Who should consider this trial
Good fit: Ideal candidates for this study are patients who are scheduled to undergo lead extraction of their pacemaker or defibrillator.
Not a fit: Patients who do not require lead extraction or are not undergoing the procedure will not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could improve patient outcomes by identifying best practices and risk factors associated with lead extraction procedures.
How similar studies have performed: While observational studies on lead extraction exist, this registry approach is relatively novel in its comprehensive data collection and analysis.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Undergoing lead extraction Exclusion Criteria: * registry--n/a
Where this trial is running
Portland, Oregon
- Charles Henrikson — Portland, Oregon, United States (Recruiting)
Study contacts
- Principal investigator: Charles Henrikson, MD — 503-494-0331
- Study coordinator: Charles Henrikson, MD
- Email: henrikso@ohsu.edu
- Phone: 503-494-0331
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.